Medicines Australia CEO Tim James announced over the weekend his resignation effective January 2016 from the leadership role of the pharmaceutical sector peak body.
Medicines Australia Interim Chairman Wes Cook thanked Tim for his strong contribution to the Australian medicines industry during a very difficult period for the sector:
“Tim has been a passionate advocate for the industry during his tenure as CEO through a most challenging period and he departs with our deep thanks and best wishes,” says Cook.
Cook pointed to a number of achievements under James’s leadership including:
- finalising negotiations for the latest five-year edition of the MA Industry Code of Conduct and smoothly implementing its new measures;
- elevating the communications function and bringing MA into the digital and social media era with a new website and social platforms;
- strongly seeking and supporting recent positive measures for the sector including the Industry Growth Centre, Health Industry Forum, Innovation Statement, Free Trade Agreements, and the Medical Research Future Fund; and
- fostering improved engagement with patient organisations including the launch of the updated edition of the Working Together Guide.
James says he is ready for a new challenge in the new year and eager to be able to lead and shape reform in other sectors of the economy during this era of disruption and innovation.
The Board will commence a process to recruit for a new CEO in 2016